Clinical trials of the CytoRich specimen-preparation device for cervical cytology - Preliminary results

被引:30
作者
Wilbur, DC
Facik, MS
Rutkowski, MA
Mulford, DK
Atkison, KM
机构
[1] Cytopathology Unit, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
关键词
cervical smears; cytological techniques; automation; CytoRich;
D O I
10.1159/000332300
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OBJECTIVE: To obtain preliminary data on the Roche CytoRich thin-layer system for the preparation of gynecologic cytology specimens, derived from a preclinical startup evaluation of the instrument and comparing the CytoRich method to conventional smears. STUDY DESIGN: At six different clinical sites, 286 pairs of conventional and CytoRich slides derived from the same patient sample were compared for the following: final Bethesda classification diagnosis, specimen adequacy and presence of microorganisms. RESULTS: The study showed agreement between the methods for an exact Bethesda diagnosis in 78% and agreement within one Bethesda diagnosis category in 95%. The CytoRich method diagnosed more cases of squamous intraepithelial lesion (SIL) than did the conventional method, and the differences in Sn detection were statistically significant. The CytoRich method idensimilar numbers of cases with microorganisms as did the conventional smears, and the CytoRich system improved overall specimen adequacy as compared to the conventional method, with fewer cases of unsatisfactory and less-than optimal smears. CONCLUSION: The CytoRich method may improve the overall sensitivity and specificity of the cervical cytology procedure. Clinical trials to verify these preliminary data are ongoing.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 30 条
[1]  
CHRISTOPHERSON WM, 1976, CANCER, V38, P1357, DOI 10.1002/1097-0142(197609)38:3<1357::AID-CNCR2820380340>3.0.CO
[2]  
2-A
[3]   ESTIMATION OF SCREENING ERROR RATE FROM OBSERVED DETECTION RATES IN REPEATED CERVICAL CYTOLOGY [J].
COPPLESON, LW ;
BROWN, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 119 (07) :953-958
[4]  
CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO
[5]  
2-B
[6]  
DICKINSON L E, 1975, Gynecologic Oncology, V3, P1, DOI 10.1016/0090-8258(75)90001-3
[7]  
FROST JK, 1969, OBSTET GYNECOL SURV, V24, P909
[8]  
GAY JD, 1985, ACTA CYTOL, V29, P1043
[9]  
GEYER JW, 1993, DIAGN CYTOL, V9, P1
[10]  
HUSSAIN OAN, 1974, J CLIN PATHOL, V27, P934